Content Currently Unavailable
Article | 2026 Retina World Congress
Peptide eye drop could offer a noninvasive alternative to injections for nAMD treatment
Phase 1 data showed that investigational CG-P5 eye drop therapy reduced central retinal thickness.
Content Currently Unavailable







